EMEA-002744-PIP01-19-M01 - paediatric investigation plan

atropine sulfate

Key facts

• Active substance:
  atropine sulfate
• Therapeutic area:
  Ophthalmology
• Decision number:
  P/0039/2024
• PIP number:
  EMEA-002744-PIP01-19-M01
• Pharmaceutical form(s):
  Eye drops, solution
• Condition(s) / indication(s):
  Treatment of myopia
• Route(s) of administration:
  Topical use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  07/02/2024
• Compliance check done:
  No

Decision

P/0039/2024 : EMA decision of 7 February 2024 on the acceptance of a modification of an agreed paediatric investigation plan for atropine sulfate (EMEA-002744-PIP01-19-M01)

Adopted Reference Number: EMA/28206/2024